Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A hybrid Bayesian adaptive design for dose response trials.

Mark Chang1, Shein-Chung Chow

  • 1Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, USA. mark.chang@mpi.com

Journal of Biopharmaceutical Statistics
|July 19, 2005
PubMed
Summary

This study introduces a hybrid frequentist-Bayesian continual reassessment method (CRM) and utility-adaptive randomization for adaptive clinical trial designs. This approach enhances dose-response modeling and patient allocation in early development for multiple endpoints.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pyruvate kinase activator etavopivat (FT-4202) limits pulmonary and systemic sequelae of sepsis in a mouse LPS model.

American journal of physiology. Lung cellular and molecular physiology·2026
Same author

Power Calculation for Non-inferiority Test Based on Linear Combination of Two Correlated Binary Endpoints.

Therapeutic innovation & regulatory science·2026
Same author

Controversial issues in clinical investigation of rare disease drug development.

Journal of biopharmaceutical statistics·2026
Same author

Switching Design for Assessment of Interchangeability in Biosimilar Studies.

Pharmaceutics·2026
Same author

Comparative Efficacy of Daratumumab Based Regimens in Patients With Relapsed-Refractory Multiple Myeloma (RRMM) Aged 70 and Above: A Multicenter Study.

European journal of haematology·2026
Same author

Acupuncture for acute musculoskeletal pain in the emergency department and clinic: a pragmatic randomized trial.

Pain medicine (Malden, Mass.)·2025

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Pharmacometrics

Background:

  • Adaptive design methods are increasingly popular for dose-response trials in early clinical development.
  • These methods offer flexibility by utilizing accrued data from ongoing trials.

Purpose of the Study:

  • To develop a hybrid frequentist-Bayesian continual reassessment method (CRM) for dose-response trials.
  • To integrate utility-adaptive randomization for clinical trial designs with multiple endpoints.
  • To enhance probability modeling using a flexible, multi-parameter hyperlogistic function family.

Main Methods:

  • Developed a hybrid frequentist-Bayesian continual reassessment method (CRM).
  • Incorporated utility-adaptive randomization for trials with multiple endpoints.

Related Experiment Videos

  • Utilized a hyperlogistic function family for flexible probability modeling.
  • CRM continuously reassesses dose-response relationships based on accrued trial data.

    • Main Results:

    • The proposed CRM allows for dynamic decision-making based on updated dose-response models.
    • Utility-adaptive randomization facilitates assigning more patients to superior treatment arms.
    • Computer simulations were used to evaluate the operating characteristics of the proposed method.

    Conclusions:

    • The hybrid frequentist-Bayesian CRM combined with utility-adaptive randomization offers a flexible and efficient approach for adaptive clinical trial designs.
    • This methodology improves dose-response modeling and patient allocation in early-phase drug development, particularly for trials with multiple endpoints.